Received for publication January 5, 2005.
Revised April 13, 2005.
Accepted for publication April 19, 2005.

Prevention of Mrp2 Activity Impairment in Ethinylestradiol-Induced Cholestasis by Ursodeoxycholate in the Rat

Abstract

EE induces cholestasis by affecting bile salt-dependent and -independent fractions of the bile flow. The decrease in bile salt-independent flow is thought to be due, in part, to a reduction in the expression of the canalicular transporter Mrp2. The impact of modulation of Mrp2 function by UDC in EE cholestasis is unknown. We evaluated the protective effect of UDC on EE-induced impairment of Mrp2 activity in vivo and in isolated hepatocytes, by using the substrate dinitrophenyl-S-glutathione (DNP-SG). EE was administered to male Wistar rats at a dose of 5 mg/Kg, i.p., for 5 days. UDC was coadministered with EE at a dose of 25 mg/kg body wt, i.p, for the same period. EE alone reduced DNP-SG biliary excretion by 55% when compared to controls. Coadministration with UDC partially restored the alteration. Secretion rate of DNP-SG was decreased by 30% in isolated hepatocytes from EE-treated rats, but, contrary to in vivo results, UDC coadministration did not restore DNP-SG transport, likely as a consequence of bile salt washout resulting from the isolation procedure. As a confirmation, tauroursodeoxycholate hepatocyte preloading significantly increased Mrp2 activity. Western blotting analysis of Mrp2 indicated that EE administration significantly reduced its level in total and plasma membranes and that UDC coadministration failed to revert this alteration. In conclusion, UDC improvement in Mrp2 transport activity in vivo likely derived from a direct enhancement of Mrp2 function rather than from a restoration of its expression levels. This provides a novel mechanism explaining the beneficial effects of UDC in EE-induced cholestasis.

Key words: ABC transporters, drug secretion, glutathione conjugates, hepatobiliary transport, isolated hepatocytes, liver disease, membrane transport, MRP, organic anion transport

This article has been cited by other articles:

				M. L. Ruiz, S. S.M. Villanueva, M. G. Luquita, S.-i. Ikushiro, A. D. Mottino, and V. A. Catania Beneficial Effect of Spironolactone Administration on Ethynylestradiol-Induced Cholestasis in the Rat: Involvement of Up-Regulation of Multidrug Resistance-Associated Protein 2 Drug Metab. Dispos., November 1, 2007; 35(11): 2060 - 2066. [Abstract] [Full Text] [PDF]